Samrat Pharmachem Limited

BSE:530125 Stock Report

Market Cap: ₹831.7m

Samrat Pharmachem Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Lalit Mehta

Chief executive officer

₹4.8m

Total compensation

CEO salary percentage100.00%
CEO tenure33.4yrs
CEO ownership14.0%
Management average tenure10.1yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Lalit Mehta's remuneration changed compared to Samrat Pharmachem's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

₹16m

Jun 30 2025n/an/a

₹48m

Mar 31 2025₹5m₹5m

₹71m

Dec 31 2024n/an/a

₹89m

Sep 30 2024n/an/a

₹65m

Jun 30 2024n/an/a

₹36m

Mar 31 2024₹5m₹5m

₹22m

Dec 31 2023n/an/a

₹225k

Sep 30 2023n/an/a

₹18m

Jun 30 2023n/an/a

₹79m

Mar 31 2023₹4m₹4m

₹166m

Dec 31 2022n/an/a

₹244m

Sep 30 2022n/an/a

₹287m

Jun 30 2022n/an/a

₹256m

Mar 31 2022₹4m₹4m

₹172m

Dec 31 2021n/an/a

₹117m

Sep 30 2021n/an/a

₹68m

Jun 30 2021n/an/a

₹55m

Mar 31 2021₹2m₹2m

₹53m

Dec 31 2020n/an/a

₹42m

Sep 30 2020n/an/a

₹31m

Jun 30 2020n/an/a

₹32m

Mar 31 2020₹2m₹2m

₹42m

Dec 31 2019n/an/a

₹51m

Sep 30 2019n/an/a

₹50m

Jun 30 2019n/an/a

₹34m

Mar 31 2019₹2m₹2m

₹15m

Compensation vs Market: Lalit's total compensation ($USD54.20K) is about average for companies of similar size in the Indian market ($USD46.16K).

Compensation vs Earnings: Lalit's compensation has been consistent with company performance over the past year.

CEO

Lalit Mehta (89 yo)

33.4yrs
Tenure
₹4,800,000
Compensation

Mr. Lalit Damodar Mehta serves as the Chairman, Chief Executive Officer and Managing Director at Samrat Pharmachem Limited and has been its Non-Independent Executive Director since June 16, 1992. Mr. Mehta...

Leadership Team

NamePositionTenureCompensationOwnership
Lalit Mehta
Founderno data₹4.80m13.97%
₹ 116.2m
Rajesh Mehta
CFO & Non-Independent Executive Director17.6yrs₹4.20m12.41%
₹ 103.2m
Nishant Kankaria
Company Secretary & Compliance Officer5.5yrs₹271.00kno data
Megh Mehta
Non-Independent Executive Director10.1yrs₹2.10m1.76%
₹ 14.6m
10.1yrs
Average Tenure
61yo
Average Age

Experienced Management: 530125's management team is seasoned and experienced (10.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lalit Mehta
Founder33.4yrs₹4.80m13.97%
₹ 116.2m
Rajesh Mehta
CFO & Non-Independent Executive Director33.4yrs₹4.20m12.41%
₹ 103.2m
Megh Mehta
Non-Independent Executive Director10.1yrs₹2.10m1.76%
₹ 14.6m
Renu Dharod
Non-Executive Independent Directorless than a year₹200.00k0.00081%
₹ 6.7k
Manishkumar Pipalia
Non-Executive Independent Director1.3yrs₹125.00k0.00045%
₹ 3.7k
Sachin Kothary
Non-Executive Independent Director1.3yrs₹125.00k0.00016%
₹ 1.3k
Megha Jain
Non-Executive Independent Director1.3yrs₹100.00kno data
1.3yrs
Average Tenure
56yo
Average Age

Experienced Board: 530125's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 05:46
End of Day Share Price 2025/11/18 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Samrat Pharmachem Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.